Key Points Wall Street analysts have raised price targets on Abbott, citing accelerating growth in its Medical Devices segment. Abbott's diabetes, electrophysiology, and new Exact Sciences cancer-screening businesses are driving stronger sales and earnings. Abbott's future dividend increases depend on turning growth investments into stronger cash flow. 10 stocks we like better than Abbott Laboratories › A Dividend King is a company that's raised its dividend for at least 50 years consecutively. Abbott Laboratories (NYSE: ABT) , for example, is one such company, having raised its dividend for 54 straight years. But that's not really why Wall Street is bullish on the stock.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.